GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Market Cap

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Market Cap : ¥7,265.1 Mil (As of Dec. 15, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zhejiang Ausun Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥8.34. Zhejiang Ausun Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 830.3 Mil. Therefore, Zhejiang Ausun Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥6,924.7 Mil.

Zhejiang Ausun Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (¥6,025.6 Mil) to Jun. 2024 (¥5,960.3 Mil) but then increased from Jun. 2024 (¥5,960.3 Mil) to Sep. 2024 (¥6,924.7 Mil).

Zhejiang Ausun Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥10,451.4 Mil) to Dec. 2022 (¥9,564.5 Mil) and declined from Dec. 2022 (¥9,564.5 Mil) to Dec. 2023 (¥7,834.4 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zhejiang Ausun Pharmaceutical Co's Enterprise Value for Today is ¥6,542.8 Mil.


Zhejiang Ausun Pharmaceutical Co Market Cap Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co Market Cap Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,241.60 8,764.52 10,451.45 9,564.46 7,834.44

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,451.26 7,834.44 6,025.58 5,960.35 6,924.68

Competitive Comparison of Zhejiang Ausun Pharmaceutical Co's Market Cap

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Market Cap falls into.



Zhejiang Ausun Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Zhejiang Ausun Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥9.43571*830.297
=¥7,834.4

Zhejiang Ausun Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥8.34*830.297
=¥6,924.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Zhejiang Ausun Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Ausun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
Executives
Zheng Zhi Guo Directors, senior managers
Zhang Hua Dong Directors, senior managers
Liu Bing Director

Zhejiang Ausun Pharmaceutical Co Headlines

No Headlines